精子DNA碎片化:如何检测、何时检测及异常结果处理——临床实用迷你综述
本迷你综述提出精子DNA碎片化(SDF)的临床实用框架,涵盖检测方法、检测时机与适用人群。SDF反映DNA链断裂,可能损害胚胎发育、生殖结局及子代健康,尤其当卵母细胞修复能力有限时。管理以男科优化为首选,持续高SDF者可选择性使用睾丸精子行ICSI。
要点
- SDF检测应基于临床指征,而非普遍筛查。
- 管理优先男科优化,一个生精周期后复查。
- 持续高SDF表型可考虑睾丸精子ICSI。
核心结论
- SDF评估应嵌入临床指征与质量管理体系,追求精准而非广泛检测。
- 持续高SDF表型者选择性使用睾丸精子行ICSI与更低流产率和更高活产率相关。
研究设计与样本
- 迷你综述,总结SDF机制、检测方法与临床管理框架。
- 强调现有证据以观察性研究为主,缺乏表型靶向随机对照试验。
主要发现
- SDF机制涉及染色质包装缺陷与氧化应激的两步假说。
- 父源与母源衰老共同影响DNA损伤的形成与修复。
- 检测涵盖单链与双链断裂(DSB)及DSB特异性平台,需注意检测特异性截断值。
关键数值与推荐
- 管理策略包括生活方式调整、抗氧化补充、生殖道感染治疗、精索静脉曲张修复及选择性激素治疗。
- 治疗后一个生精周期复查SDF。
- 持续高SDF者选择性使用睾丸精子行ICSI及实验室辅助手段。
临床怎么用
- 将SDF检测纳入孕前保健,视精子染色质完整性为生殖与跨代健康决定因素。
- 在质量管理项目中系统审计SDF检测指征、治疗效果及ART结局。
局限性
- 现有证据以观察性研究为主,缺乏表型靶向随机对照试验。
- DSB特异性检测方法有待验证。
- 子代纵向随访不足,跨代效应尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sperm DNA fragmentation (SDF) represents strand breaks that may compromise embryo development, reproductive outcomes, and offspring health, particularly when the oocyte's repair capacity is limited. This mini-review provides a clinically pragmatic framework addressing how to test, when to test, and whom to test for SDF, translating biological and laboratory insights into actionable andrology practice. The mechanistic basis of SDF is summarized, including the two-step hypothesis linking defective chromatin packaging to oxidative stress, and the combined influence of paternal and maternal aging on the creation and repair of DNA lesions. Contemporary methods for detecting both single- and double-strand breaks (DSBs), as well as DSB-specific platforms, are reviewed with emphasis on assay-specific cut-offs and clinical indications. Management strategies are outlined, prioritizing andrological optimization through lifestyle modification, antioxidant supplementation, treatment of genital tract infection, varicocele repair, and selected hormonal therapy, followed by retesting after one spermatogenic cycle. For persistently high SDF, selective use of testicular sperm for ICSI (Testi-ICSI) and laboratory adjuncts is discussed, supported by evidence of lower miscarriage and higher live-birth rates in defined high-SDF phenotypes. The limitations of the existing observational evidence base-particularly the paucity of phenotype-targeted randomized controlled trials-are highlighted. The review also underscores the value of embedding SDF testing within quality-managed programs and incorporating systematic audits of indications, treatment effects, and ART outcomes. Beyond ART, SDF assessment is positioned within preconception care, recognizing sperm chromatin integrity as a determinant of reproductive and intergenerational health. Future priorities include randomized trials comparing testicular and ejaculated sperm for ICSI in high-SDF cohorts, validation of DSB-specific assays, and longitudinal offspring follow-up to clarify intergenerational effects. This integrative approach promotes precision rather than proliferation of testing, aligning molecular insight with clinical prudence to improve reproductive and generational outcomes.
引用
- Esteves SC, Humaidan P. Sperm DNA fragmentation: how to test, when to test, and what to do with abnormal results-a pragmatic mini-review for clinical practice. Hum Reprod. 2026. PMID: 42049202. doi:10.1093/humrep/deag056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。